• Mashup Score: 7

    People dying in UK hospitals without specialist palliative care input frequently have “significant and poorly identified unmet needs,” finds a UK-wide evaluation-;the first of its kind-;published online in the journal BMJ Supportive & Palliative Care.

    Tweet Tweets with this article
    • Majority of dying patients in @NHSuk hospitals have unmet needs, says @SimonTavabie & @drol007 et al research in @BMJ_SPCare https://t.co/tOLFnhmwcb via @daniellis__

  • Mashup Score: 1

    Two anti-inflammatory drugs, abatacept and infliximab, reduced deaths among patients hospitalized with severe COVID-19, according to a national study led by Washington University School of Medicine in St. Louis. William G. Powderly, MD, (right) who led the large clinical trial, discusses patient conditions with Maanasi Samant, MD, in the intensive care unit at Barnes-Jewish Hospital, one of the…

    Tweet Tweets with this article
    • “Fewer patients died when treated with standard care plus either infliximab or abatacept, compared with patients who received standard care plus a placebo. Treatment with the third drug, cenicriviroc, was stopped early because the data showed no benefit.” https://t.co/zVZAOXpPS5

  • Mashup Score: 0

    At the start of the coronavirus disease 2019 (COVID-19) pandemic, analog techniques like nasopharyngeal swab specimens for polymerase chain reaction (PCR) testing were prominent. The widespread use of nonpharmaceutical interventions (NPIs) such as facemasks and social distancing was reminiscent of the influenza outbreak in 1918.

    Tweet Tweets with this article
    • The vital role of smartphone apps during the COVID-19 pandemic #NBTintheNews https://t.co/vVZNQfhwXS